Form 8-K - Current report:
SEC Accession No. 0000950170-23-027274
Filing Date
2023-06-09
Accepted
2023-06-09 16:26:47
Documents
12
Period of Report
2023-06-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230608.htm   iXBRL 8-K 51684
  Complete submission text file 0000950170-23-027274.txt   168274

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230608_pre.xml EX-101.PRE 9830
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230608.xsd EX-101.SCH 2454
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230608_lab.xml EX-101.LAB 13350
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230608_htm.xml XML 4691
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 231005678
SIC: 2834 Pharmaceutical Preparations